ClinConnect ClinConnect Logo
Search / Trial NCT03632538

AKI Cardiosurgery Diagnostic Study (AKI-CDS)

Launched by UNIVERSITY OF ROSTOCK · Aug 14, 2018

Trial Information

Current as of July 22, 2025

Unknown status

Keywords

Acute Kidney Injury Cardiac Surgery

ClinConnect Summary

Acute kidney injury (AKI) is an abrupt loss of kidney function and occurs in up to 5-40% of patients who undergo cardiac surgery; dialysis being required in approximately 2-15% of all patients. AKI is a common problem in critically ill patients and is independently from underlying diseases associated with increased morbidity and mortality (to progressive loss of kidney function, cardiovascular disease, and death). Unfortunately, chronic kidney disease is often overlooked in its earliest, most treatable stages. Implementation of novel biomarkers into the clinical practice that reliably ident...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Female or male, at least 18 years old
  • Ability to consent to the study by patient or legal representative
  • Cardiac surgery with use of extracorporeal circulation (ECC)
  • Bypass (\> 2; ACB) or bypass + heart valve surgery
  • Two or three heart-valve operation
  • Exclusion Criteria:
  • Dialysis-dependent patients with chronic, end-stage renal failure
  • Pre-existing renal replacement therapy
  • Infused prognosis (expected death in ≤ 12 hours despite maximal therapy)
  • Inability to consent of participation in the research project, of the patient or of the patients representative
  • Aortic surgery
  • Endocarditis
  • (Only) partial sternotomy (eg. aortic valve surgery)

About University Of Rostock

The University of Rostock is a prestigious academic institution located in Germany, dedicated to advancing medical research and education. With a strong emphasis on interdisciplinary collaboration, the university is committed to conducting innovative clinical trials that address pressing health challenges. Its research initiatives are supported by state-of-the-art facilities and a team of experienced professionals, enabling the exploration of cutting-edge therapies and interventions. The University of Rostock aims to contribute to the scientific community and improve patient outcomes through rigorous clinical investigation and the dissemination of knowledge.

Locations

Rostock, , Germany

Patients applied

0 patients applied

Trial Officials

Martin Sauer, MD

Principal Investigator

University Hospital of Rostock, Germany

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials